MAPT and Alzheimer disease: On the other hand, Choi et al. (2014) demonstrated the robust deposition of Aβ and filamentous tau in a hydrogel-based 3D model of AD using genetically modified human neural stem cells which overexpressed mutant APP and PSEN1 (Kim et al., 2015).